In recent years, the Chinese Communist Party (CCP) has directly supported, facilitated, and exerted strategic control over the development of the Chinese pharmaceutical industry, a substantial portion of which is centered in Wuhan city.
Ryan Clarke
Author
Ryan Clarke is the Co-Founder/Managing Director of the CCP BioThreats Initiative and Senior Fellow at the National University of Singapore. He has served in leadership positions across defense and intelligence, investment banking, biodefense, strategic assessments, and specialized law enforcement units. He holds a Ph.D. from the University of Cambridge.
